- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

H.R. 4639
U.S. House•In House Committee
Summary
H.R. 4639, the Infertility Treatment Affordability Act of 2025, was introduced in the House on Jul 23, 2025 by Rep. Mike Carey (R) with 4 co-sponsors. It was referred to Ways And Means, and last saw action on Jul 23, 2025: Referred to the House Committee on Ways and Means.
Record
Text
H.R. 4639 has 4 co-sponsors.
hb4639/introduced-in-house.txt119 HR 4639 IH: Infertility Treatment Affordability Act of 2025U.S. House of Representatives2025-07-23text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.I 119th CONGRESS 1st Session H. R. 4639 IN THE HOUSE OF REPRESENTATIVES July 23, 2025 Mr. Carey (for himself, Mr. Landsman , and Mr. Miller of Ohio ) introduced the following bill; which was referred to the Committee on Ways and Means A BILLTo amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments.1.Short titleThis Act may be cited as the Infertility Treatment Affordability Act of 2025 .2.Credit for infertility treatments(a)In generalSubpart A of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting before section 24 the following new section:23A.Credit for infertility treatments(a)Allowance of creditIn the case of an eligible individual, there shall be allowed as a credit against the tax imposed by this chapter for the taxable year an amount equal to 50 percent of the qualified infertility treatment expenses paid or incurred during the taxable year.(b)Limitations(1)Dollar limitationThe amount of the credit under subsection (a) for any taxable year shall not exceed the excess (if any) of—(A)the dollar amount in effect under section 23(b)(1) for the taxable year, over(B)the aggregate amount of the credits allowed under subsection (a) for all preceding taxable years.(2)Income limitation(A)In generalThe amount otherwise allowable as a credit under subsection (a) for any taxable year (determined after the application of paragraph (1) and without regard to this paragraph and subsection (c)) shall be reduced (but not below zero) by an amount which bears the same ratio to the amount so allowable as—(i)the amount (if any) by which the taxpayer’s adjusted gross income exceeds the dollar amount in effect under clause (i) of section 23(b)(2)(A), bears to(ii)$40,000.(B)Determination of adjusted gross incomeFor purposes of subparagraph (A), adjusted gross income shall be determined without regard to sections 911, 931, and 933.(3)Portion of credit refundable(A)In generalSo much of the credit allowed under subsection (a) for any taxable year (determined after the applications of paragraphs (1) and (2)) as does not exceed $5,000 shall be treated as a credit allowed under subpart C and not as a credit allowed under this subpart.(B)Adjustments for inflation(i)In generalIn the case of a taxable year beginning after December 31, 2025, the $5,000 amount in subparagraph (A) shall be increased by an amount equal to—(I)such dollar amount, multiplied by(II)the cost-of-living adjustment determined under section 1(f)(3) for the calendar year in which the taxable year begins, determined by substituting calendar year 2024 for calendar year 2016 in subparagraph (A)(ii) thereof.(ii)RoundingIf any amount as increased under clause (i) is not a multiple of $10, such amount shall be rounded to the nearest multiple of $10.(4)Denial of double benefit(A)In generalAny qualified infertility treatment expense taken into account for purposes of any deduction (or any credit other than the credit allowed under this section) shall be reduced by the amount of the credit allowed under subsection (a) with respect to such expense.(B)GrantsNo credit shall be allowed under subsection (a) for any expense to the extent that reimbursement or other funds in compensation for such expense are received under any Federal, State, or local program.(C)Insurance reimbursementNo credit shall be allowed under subsection (a) for any expense to the extent that payment for such expense is made, or reimbursement for such expense is received, under any insurance policy.(c)Carryforwards of unused credit(1)In generalIf the portion of the credit allowable under subsection (a) which is allowed under this subpart exceeds the limitation imposed by section 26(a) for such taxable year reduced by the sum of the credits allowable under this subpart (other than this section and section 25D), such excess shall be carried to the succeeding taxable year and added to the credit allowable under subsection (a) for such succeeding taxable year.(2)LimitationNo credit may be carried forward under this subsection to any taxable year after the 5th taxable year after the taxable year in which the credit arose. For purposes of the preceding sentence, credits shall be treated as used on a first-in, first-out basis.(d)Qualified infertility treatment expensesFor purposes of this section—(1)In generalThe term qualified infertility treatment expenses means amounts paid or incurred for the treatment of infertility if such treatment is provided—(A)by a physician, or other medical practitioner, licensed in the United States, and(B)pursuant to a diagnosis of infertility by a physician licensed in the United States.(2)Treatments in advance of infertility arising from medical treatmentsFor purposes of this section:(A)In generalIn the case of expenses incurred in advance of a diagnosis of infertility for fertility preservation procedures which are conducted prior to medical procedures that, as determined by a physician licensed in the United States, may cause involuntary infertility or sterilization, such expenses shall be treated as qualified infertility treatment expenses—(i)notwithstanding paragraph (1)(B), and(ii)without regard to whether a diagnosis of infertility subsequently results.(B)Exception for procedures designed to result in infertilityExpenses for fertility preservation procedures in advance of a procedure designed to result in infertility or sterilization shall not be treated as qualified infertility treatment expenses.(3)InfertilityThe term infertility —(A)means the inability to conceive or to carry a pregnancy to live birth,(B)includes iatrogenic infertility resulting from medical treatments such as chemotherapy, radiation, or surgery, and(C)does not include infertility or sterilization resulting from a procedure designed for such purpose.(e)Eligible individualFor purposes of this section, the term eligible individual means an individual—(1)who has been diagnosed with infertility by a physician licensed in the United States, or(2)with respect to whom a physician licensed in the United States has made the determination described in subsection (d)(2)(A).(f)Married couples must file joint returnsRules similar to the rules of paragraphs (2), (3), and (4) of section 21(e) shall apply for purposes of this section..(b)Conforming amendments(1)The table of sections for subpart A of part IV of subchapter A of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting before the item relating to section 24 the following new item:Sec. 23A. Credit for infertility treatments..(2)Section 23(c)(1) of such Code is amended by striking section 25D and inserting sections 23A and 25D .(3)Section 25(e)(1)(C) of such Code is amended by inserting , 23A, after 23 .(c)Effective dateThe amendments made by this section shall apply to taxable years beginning after December 31, 2024.
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2025-07-23
- Passed House
- Passed Senate
- Conference
- To President
- Became Law
To amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments.
Sponsors
Rep. Mike Carey (R) sponsors H.R. 4639, and 4 members have co-sponsored it, 2 of them from the day it was introduced.

Rep. · R–OH-15 · Sponsor
Introduced Jul 23, 2025

Rep. · D–OH-1 · Co-sponsor
Joined Jul 23, 2025 · Original

Rep. · R–OH-7 · Co-sponsor
Joined Jul 23, 2025 · Original

Rep. · D–VA-7 · Co-sponsor
Joined Sep 15, 2025

Rep. · D–NY-4 · Co-sponsor
Joined Oct 31, 2025
Committees
H.R. 4639 went before 1 committee: Ways and Means.
Actions
H.R. 4639 has taken 2 actions since Jul 23, 2025.
| Chamber | Action | |||
|---|---|---|---|---|
Jul 23, 2025 | House | Introduced in House | ||
Jul 23, 2025 | House | Referred to the House Committee on Ways and Means.Ways and Means Committee |
Votes
H.R. 4639 has not gone to a roll call.
Titles
H.R. 4639 goes by 3 titles, 1 of them short titles.
- Infertility Treatment Affordability Act of 2025 — Display Title
- To amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments. — Official Title as Introduced
- Infertility Treatment Affordability Act of 2025 — Short Title(s) as Introduced
Lobbying
3 clients hired 3 firms and 10 registered lobbyists who named H.R. 4639 in 7 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.
Filed under Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products, Defense.
Clients
Who paid to be heard, by how many filings named the bill.
| Client | Business | State | Firms | Filings | Reported |
|---|---|---|---|---|---|
| FERRING PHARMACEUTICALS, INC. | — | District of Columbia | 1 | 4 | — |
| EMD SERONO, INC. | Client is a biopharmaceutical company. | Massachusetts | 1 | 2 | $100K |
| DEMAND PROGRESS ACTION, INC | — | Maryland | 1 | 1 | — |
Firms
Registrants who filed on the bill, by filings.
| Registrant | Clients | Filings | Reported |
|---|---|---|---|
| FERRING PHARMACEUTICALS, INC. | 1 | 4 | — |
| THE MCMANUS GROUP | 1 | 2 | $100K |
| DEMAND PROGRESS ACTION, INC | 1 | 1 | — |
Lobbyists
Named on the filings that cite the bill.
| Lobbyist | Firms | Clients | Filings |
|---|---|---|---|
| TEGAN GELFAND | 1 | 1 | 4 |
| ALEX WHALEN | 1 | 1 | 2 |
| JOHN MCMANUS | 1 | 1 | 2 |
| COLIN MCGLYNN | 1 | 1 | 1 |
| EMILY PETERSON-CASSIN | 1 | 1 | 1 |
| HAJAR HAMMADO | 1 | 1 | 1 |
| LAWREN GEER | 1 | 1 | 1 |
| NICOLAS KHARRAZIAN | 1 | 1 | 1 |
| SEAN VITKA | 1 | 1 | 1 |
| TIMOTHY CLARK | 1 | 1 | 1 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.
| Client | Registrant | Period | Reported | Document |
|---|---|---|---|---|
| FERRING PHARMACEUTICALS, INC. | FERRING PHARMACEUTICALS, INC. | 2025 fourth_quarter | $290K | 4th Quarter - Report |
| FERRING PHARMACEUTICALS, INC. | FERRING PHARMACEUTICALS, INC. | 2026 second_quarter | $250K | 2nd Quarter - Report |
| FERRING PHARMACEUTICALS, INC. | FERRING PHARMACEUTICALS, INC. | 2026 first_quarter | $220K | 1st Quarter - Report |
| FERRING PHARMACEUTICALS, INC. | FERRING PHARMACEUTICALS, INC. | 2025 third_quarter | $160K | 3rd Quarter - Report |
| EMD SERONO, INC. | THE MCMANUS GROUP | 2025 fourth_quarter | $50K | 4th Quarter - Termina… |
| EMD SERONO, INC. | THE MCMANUS GROUP | 2025 third_quarter | $50K | 3rd Quarter - Report |
| DEMAND PROGRESS ACTION, INC | DEMAND PROGRESS ACTION, INC | 2025 fourth_quarter | $40K | 4th Quarter - Report |
Classification
The Congressional Research Service files H.R. 4639 under Taxation, one of its 31 policy areas.
CRS Subjects
CRS assigns every bill one policy area from its 31; H.R. 4639’s is Taxation.
hr4639/policy-areas.txtConstitutional authority
The clause the sponsor cites as Congress’s power to enact H.R. 4639, as entered in the Congressional Record.
[Congressional Record Volume 171, Number 126 (Wednesday, July 23, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CAREY:H.R. 4639.Congress has the power to enact this legislation pursuantto the following:Article I Section 8[Page H3647]
Source: congress.gov · legiscan.com